Short Interest in CanSino Biologics Inc. (OTCMKTS:CASBF) Increases By 35.1%

CanSino Biologics Inc. (OTCMKTS:CASBF) was the recipient of a large growth in short interest in the month of December. As of December 15th, there was short interest totalling 20,000 shares, a growth of 35.1% from the November 30th total of 14,800 shares. Based on an average trading volume of 400 shares, the days-to-cover ratio is presently 50.0 days.

CanSino Biologics Price Performance

Shares of CASBF remained flat at C$3.75 during mid-day trading on Friday. 50 shares of the stock traded hands, compared to its average volume of 1,389. CanSino Biologics has a 52 week low of C$1.86 and a 52 week high of C$4.35. The firm’s fifty day simple moving average is C$3.86 and its two-hundred day simple moving average is C$3.02.

CanSino Biologics Company Profile

CanSino Biologics Inc develops, manufactures, and commercializes vaccines in the People's Republic of China. The company develops Convidecia and the Ad5-nCoV for Inhalation vaccines to recombinant novel coronavirus disease; Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N.